MDGS Stock Summary and Trading Ideas (Medigus Ltd. - American Depositary Shares | NASDAQ:MDGS)

Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.

Medigus Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol MDGS.

As of April 24, 2024, MDGS stock price was flat at $2.36 with million shares trading.

MDGS has a market cap of $4.47 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, MDGS stock traded as high as $36.75 and as low as $2.11.

MDGS has underperformed the market in the last year with a price return of -55.1% while the SPY ETF gained +24.2%. MDGS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -25.1% and -13.2%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

MDGS support price is $2.23 and resistance is $2.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MDGS stock will trade within this expected range on the day.